Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study.Published in:Oncology, 2025, v. 103, n. 6, p. 498, doi. 10.1159/000542693By:Karhan, Ogur;İleri, Serdar;Urakçı, Zuhat;Arvas, Hayati;Kılıç, Delyadıl Karakaş;Sezgin, Yasin;Erçek, Berrak Merit;Tunç, SezaiPublication type:Article